<--- Back to Details
| First Page | Document Content | |
|---|---|---|
 Date: 2016-05-06 09:10:01Food and Drug Administration Federal assistance in the United States Clinical research Pharmaceutical industry Clinical trial Design of experiments Investigational New Drug Grant Costs in English law Federal grants in the United States Funding Funding opportunity announcement |
Add to Reading List |
Department of Defense Neurofibromatosis Research Program | Morphochem’s Investigational New Drug (IND) application accepted by FDA – Novel antibacterial for IV treatment of CDI ready to move to Phase 2 Munich (Germany), June 22, 2016 — Morphochem, a clinical-stage pharmaceDocID: 1uvYN - View Document |
| Guidance for Industry Content and Format of Investigational New Drug Applications (INDs) for Phase 1 Studies of Drugs, Including Well-Characterized, Therapeutic,DocID: 1sDEk - View Document |
| Emergency Use: means the use of a test article on a human subject in a life-threatening situation inDocID: 1riMu - View Document |
| Microsoft Word - 7494fnl.docDocID: 1qYy2 - View Document |
| Microsoft WorddocDocID: 1qVAJ - View Document |